8-K

Company

UroGen Pharma Ltd.

Filed

May 28, 2019

Period of Report

May 21, 2019

Accession Number

0001193125-19-158432

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →